Chemo's muscle impact under the microscope in small breast cancer study

NCT ID NCT06536556

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how a single round of chemotherapy affects the muscles of women with early-stage breast cancer. Researchers compared three common chemo regimens: paclitaxel alone, paclitaxel plus trastuzumab, and paclitaxel plus carboplatin. They took muscle biopsies and measured strength, body composition, and quality of life before and four days after treatment. The study was terminated early and only enrolled 5 participants, so the findings are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
paclitaxel, trastuzumab, carboplatin
What this could lead to
If successful, this could help doctors understand how chemotherapy affects muscle health in breast cancer patients, potentially leading to better supportive care.
What could go wrong
The study was terminated early with only 5 participants, so results are very limited and may not be reliable. It was designed to observe short-term changes, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut de cancérologie Strasbourg europe

    Strasbourg, 67033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.